UGT1A1 polymorphisms as a pharmacogenetic markers for prediction of irinotecan-induced toxicities in metastatic colorectal cancer

Q4 Medicine

Libri Oncologici Pub Date : 2019-08-06 DOI:10.20471/lo.2019.47.01.05

P. Vuković, T. Žigman, M. Vučetić, S. Ramić, I. Kirac

引用次数: 0

查看原文本刊更多论文

UGT1A1多态性作为预测伊立替康诱导的转移性结直肠癌毒性的药理学标记

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Libri Oncologici Medicine-Oncology

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： - Genitourinary cancer: the potential role of imaging - Hemoglobin level and neoadjuvant chemoradiation in patients with locally advanced cervical carcinoma